THYMIC EPITHELIAL TUMOR

Clinical trials for THYMIC EPITHELIAL TUMOR explained in plain language.

Never miss a new study

Get alerted when new THYMIC EPITHELIAL TUMOR trials appear

Sign up with your email to follow new studies for THYMIC EPITHELIAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

New hope for rare cancer patients as trial tests novel drug

Disease control Recruiting now

This study is testing a new drug called PT-112 for people with advanced thymoma or thymic carcinoma, rare cancers that have returned or worsened after standard chemotherapy. The main goal is to see if the drug can shrink tumors. Participants will receive PT-112 by IV infusion in …

Matched conditions: THYMIC EPITHELIAL TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

THYMIC EPITHELIAL TUMOR

Get alerted when new THYMIC EPITHELIAL TUMOR trials appear

New hope for rare cancer patients as trial tests novel drug